Oral cancer has emerged as a silent public health emer-gency in Pakistan. The unchecked con-sumption of gutka, naswar, paan and betel nut is a major driver of this crisis. These carcinogenic products ...

Nimbus Therapeutics said on Tuesday it has entered into a multi-year research and licensing agreement with Eli Lilly to ...

MANGALURU: Radiation therapy for head and neck cancers is often effective against tumours, but patients frequently experience ...

Tea may offer powerful health benefits, but how it is prepared and consumed matters. Tea has a long history as both a ...

Exelixis, Inc. EXEL reported preliminary, unaudited financial results for fiscal year 2025, issued financial guidance for ...

After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco ...

Execute a pivotal program for potential best-in-class BTK degrader, bexobrutideg, including Phase 2 and confirmatory Phase 3 studies to support ...

Main outcome measures Cumulative time dependent intake of preservatives, including those in industrial food brands, assessed ...

Bristol Myers Squibb is already aiming to launch more than 10 new medicines by 2030. | Bristol Myers Squibb is already aiming ...

Nimbus will use its AI to help identify drug candidates, while Lilly will contribute its metabolic-disease expertise to ...

Niktimvo™ (axatilimab-csfr) 4Q25 and full year 2025 net revenue, respectively; Syndax will report its share of the Niktimvo net profit when it reports full year 2025 results – – Ended 2025 with ...